Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNotes PayablesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Healthcare Triangle (HCTI) Short term Debt (2021 - 2025)

Historic Short term Debt for Healthcare Triangle (HCTI) over the last 5 years, with Q3 2025 value amounting to $1.5 million.

  • Healthcare Triangle's Short term Debt rose 4140.48% to $1.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.5 million, marking a year-over-year increase of 4140.48%. This contributed to the annual value of $2.6 million for FY2024, which is 3004.22% down from last year.
  • Latest data reveals that Healthcare Triangle reported Short term Debt of $1.5 million as of Q3 2025, which was up 4140.48% from $415000.0 recorded in Q2 2025.
  • Healthcare Triangle's 5-year Short term Debt high stood at $3.8 million for Q4 2023, and its period low was $415000.0 during Q2 2025.
  • Moreover, its 5-year median value for Short term Debt was $2.5 million (2022), whereas its average is $2.3 million.
  • In the last 5 years, Healthcare Triangle's Short term Debt skyrocketed by 4182.63% in 2023 and then tumbled by 7595.6% in 2025.
  • Over the past 5 years, Healthcare Triangle's Short term Debt (Quarter) stood at $2.2 million in 2021, then increased by 21.55% to $2.7 million in 2022, then soared by 41.08% to $3.8 million in 2023, then tumbled by 30.04% to $2.6 million in 2024, then tumbled by 42.26% to $1.5 million in 2025.
  • Its Short term Debt was $1.5 million in Q3 2025, compared to $415000.0 in Q2 2025 and $775000.0 in Q1 2025.